Category: prescription

Act, active, advertised, advertising, analysis, analytics, and Cosmetic, approval, business, cannabidiol, cannabis, cbd, compliance, consumer, Dispensaries & Retail, drug, FDA, FDA food safety challenge, Federal, food, GMP, good manufacturing practice, government, growing, Husch Blackewell, inactive, industry, ingredient, law, legal, legalization, legalize, legislation, letter, license, marijuana, market, marketing, medical, medicine, NDA, New Drug Application, nonprescription, OTC, prescription, product, products, Quality, recreational, regulation, regulations, regulatory, retail, safety, state, test, Testing, thc, violation, warning

FDA Issues Warning Letters on Marketing and Sale of OTC CBD Products

FDA Issues Warning Letters on Marketing and Sale of OTC CBD Products

The U.S. Food and Drug Administration (FDA) issued warning letters this month to two companies concerning the marketing and sale of over-the-counter (OTC) drug […]

analysis, analytics, Berlin, book, business, Business Analysis, CANADA, canadian, cannabis, CannaList EU, cbd, compliance, consumer, DACH, Eruopean, EU, europe, export, Federal, German, Germany, government, green, Green II, growing, Holland, import, industry, international, Israel, law, legal, legalization, legalize, legislation, Marguerite Arnold, marijuana, market, medical, medicine, patient, prescribe, prescription, product, reform, regulation, regulations, regulatory, safety, spain, Spreading Like Kudzu, state, Switzerland, thc, United States

New Book On Cannabis Describes A Global Market In Transition

New Book On Cannabis Describes A Global Market In Transition

Editor’s Note: This piece is an excerpt from Marguerite Arnold’s Green II: Spreading Like Kudzu. Click here to buy the book. THC […]

agreement, analysis, analytics, Aussie, Australia, Australian, British, business, Business Analysis, CANADA, canadian, cannabinoid, cannabis, cbd, clinic, compliance, consumer, cooperation, cultivation, drug, England, Epidiolex, EU, europe, European, export, Federal, firm, German, Germany, global, government, growing, GW Pharma, GW Pharmaceuticals, healthcare, hospital, import, industry, insurance, insure, international, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, network, NHS, patient, pharmacies, pharmacy, pool, prescribe, prescription, producer, product, production, Quality, regulation, regulations, regulatory, retail, Sativex, state, thc, THC Global, UK, union, United Kingdom, wide, world

Will Australia’s Cannabis Program Follow Canada’s Lead?

Will Australia’s Cannabis Program Follow Canada’s Lead?

The news is intriguing in a world overwhelmed with pandemic news. THC Global, a Canadian-Aussie company now raising money and signing global […]